Skip to main content
Journal of Travel Medicine logoLink to Journal of Travel Medicine
letter
. 2023 Feb 16;30(5):taad020. doi: 10.1093/jtm/taad020

Linkage disequilibrium suggests genomic stability in Omicron clades of SARS-CoV-2 from the ASEAN countries

Noriah Binti Mohd Yusof 1, Zhi Shan Khor 2, Rehan Shuhada Binti Abu Bakar 3, Kamal Hisham Bin Kamarul Zaman 4, Yu Kie Chem 5, Nur Aina Fatini 6, Nur Hazliza Binti Salleh 7, Selvanesan Sengol 8, Savuth Chin 9, Sitha Prum 10, Visal Chhe 11, Phally Vy 12, Aizzuddin Mirasin 13, Nur Amirah Ibarahim 14, Izzati Azhar 15, Muhd Haziq Fikry Abdul Momin 16, Nor Azian Hafneh 17, Hartanti Dian Ikawati 18, Hana Apsari Pawestri 19, Arie Ardiansyah Nugraha 20, Kartika Dewi Puspa 21, Archawin Rojanawiwat 22, Pilailuk Akkapaiboon Okada 23, Siripaporn Phuygun 24, Thanutsapa Thanadachakul 25, Pakorn Piromtong 26, Hoang Vu Mai Phuong 27, Ung Thi Hong Trang 28, Nguyen Phuong Anh 29, Nguyen Vu Son 30, Le Thi Thanh 31, Noorliza Mohamad Noordin 32,33,b, Joon Liang Tan 34,
PMCID: PMC10481408  PMID: 36795049

 

After more than 2 years of pandemic caused by SARS-CoV-2, COVID-19 is still a national concern in many countries worldwide. One of the key investigations is to understand the factors contributing to the evolutionary dynamics of SARS-CoV-2 as a pathogen. Currently, almost all countries have lifted border control orders and have allowed inter-country travel with minimal restrictions. This provides better resolutions on genomic patterns and the evolution of circulating SARS-CoV-2 in each community with the influence of imported strains.

In this report, we surveyed genomes of SARS-CoV-2 strains circulating in the Association of Southeast Asian Nations (ASEAN) countries. This project serves as a collaborative effort from the ASEAN Member States that had participated in the programme ‘Strengthening Laboratory Capacity on COVID-19 Bio Genomic for ASEAN Countries’. A total of 124 SARS-CoV-2 samples were collected by the national level public health laboratories: Malaysia (n = 24), Brunei Darussalam (n = 20), Cambodia (n = 20), Indonesia (n = 20), Thailand (n = 20) and Vietnam (n = 20). All samples were sequenced using short-read technology. The version of the genomes used in this study was statistically quality-assessed and preprocessed in FASTQC and Trimmomatics, respectively, prior to de novo assembly in Megahit.1–3 The genomes were submitted to GISAID by the respective laboratories (Supplementary Data 1).

Phylogenomics analyses using 210 representative genomes from the NextStrain database (accessed on 25 August 2022) as background, assigned all the genomes into four different clades in the Omicron lineage. The majority of the strains were clustered into 22B (48.39%), followed by 22L (44.35%), 22A (4.03%) and, lastly, 21K (3.23%). Each strain was clustered into a respective clade and showed a non-observable cascade-like structure, indicating the genomes of SARS-CoV-2 exerted a slow impact on evolution (Figure 1).

Figure 1.

Figure 1

(a) Unrooted representation for phylogenomics of 124 genomes yielded from this study with 210 NextStrain clade representative genomes. Each colour represented single clade. (b) Illustration of linkage disequilibrium in the SARS-CoV-2 genomes.

There are speculations on the roles of recombination in viruses, such as mechanisms for rapid repair and host adaptation, as well as viral genome integrity.4 In this study, there were no observable recombination trends in the reconstructed phylogenomics trees. Thus, the hypothesis of recombination in the SARS-CoV-2 was further tested with inter- and intra-clades PHI test of recombination. Both tests showed insignificant recombination events among the strains at a P-value of 0.405 and 0.253, respectively.

Linkage disequilibrium measures the non-random association of nucleotides at different sites. Analyses of linkage disequilibrium have been reported to be able to infer evolutionary features in pathogens.5 In this study, linkage disequilibrium analyses were performed on the genomes of the SARS-CoV-2 analysed (Table 1). Using a threshold of 0.8 for a correlation between alleles at two loci (R2), 22 sites were predicted to be under the effect of linkage disequilibrium. All the sites achieved high-confidence disequilibrium coefficients (D′) ranging from 0.96 to 1.0, which were supported by Fisher’s Exact test ranging from 3.65 × 10−37 to 1.06 × 10−10. One linkage disequilibrium was found to involve 13 out of the 22 predicted sites (LD Set 1). The sites involved 11 SNP-SNP, single SNP-INDEL and single triplet-nucleotide linkage disequilibria. The linkage disequilibrium for the remaining sites involved only SNP-SNP associations, with four (LD Set 2), three (LD Set 3) and two (LD Set 4) affected sites, respectively. Recombination processes were found to disrupt linkage disequilibrium and managed to alter the variants-associated sites.6 In this study, the positions of the linkage disequilibrium pairs ranged from 22 to 26 712 bp (Figure 1). Coupled with the PHI test of recombination, the close-to-wide pairing distances of linkage disequilibrium suggested that the genomes of SARS-CoV-2 had little to no recombination influence.

Table 1.

Details of linkage disequilibrium

Sites LD #1 LD #2 LD #1 Codon = Amino LD #2 Codon = Amino Gene
1627 T C CT[T] = L CT[C] = L nsp2
9866 C T [C]TT = L [T]TT = F nsp4
12 160 A G GA[A] = E GA[G] = E nsp8
LD Set 1 IHVdel A[TA] = I [CAT] = H [G]TC = V
21 765–21 770 tacatg S
22 917 G t C[G]G = R C[T]G = L S
23 018 G t [G]TT = V [T]TT = F S
23 040 A G C[A]A = Q C[G]A = R S
26 529 A G [A]AT = N [G]AT = D M
26 858 C T TT[C] = F TT[T] = F M
27 259 A C [A]GG = R [C]GG = R ORF6
27 382–27 384 GAT CTC GAT = D CTC = L ORF6
27 889 T C
28 330 G A GG[G] = G GG[A] = G N
12 310 A G CA[A] = Q CA[G] = Q nsp8
LD Set 2 16 616 A C A[A]T = N A[C]T = T nsp13
27 012 T C [T]TG = L [C]TG = L M
27 513 T C TA[T] = Y TA[C] = Y ORF7a
LD Set3 19 677 T G CA[T] = H CA[G] = Q nsp15
21 306 T C CG[T] = R CG[C] = R nsp16
22 812 C A A[C]G = T A[A]G = K S
LD Set 4 8991 T C G[T]A = V G[C]A = A nsp4
25 810 T C [T]TT = F [C]TT = L ORF3a

Note: The genomes will either have LD Pattern 1 or LD Pattern 2 across the positions in each LD set.

Successful reproduction in a population is the indicator of genome stability. Recombination is one of the common processes used for viral genome repair and can introduce mutations into the host (reviewed by Kockler and Gordenin).7 Hence, the process increases the diversity in a population. However, it has been reported that there is a lack of genomic diversity (low frequency of nucleotide changes) among SARS-CoV-2 strains.8 Although the recombination in SARS-CoV-2 has been discussed in multiple publications,9 the number of recombinant strains has not been found to be alarming. It was reported that only approximately 2–3% out of the total SARS-CoV-2 genomes deposited in the public database exerted recombination events.10 The recombinant strains were also predicted to be present in the population only for a short period of time. Together with all these aspects, a strong influence of linkage disequilibrium from our study suggests the stability of Omicron clades SARS-CoV-2 genomes. The stability in the genomes indicates that random nucleotide changes are less likely to occur in the SARS-CoV-2. Nucleotide changes, especially linkage disequilibrium, can have a direct influence on the virulence and vaccine effectiveness in the infected hosts. This characteristic of SARS-CoV-2 will raise public health concerns if new variants are identified. Further studies are needed to evaluate the linkage disequilibrium among all SARS-CoV-2 clades and the impact on their fitness factor. This study also provides better insights for other researchers to thoroughly customize specific parameters to analyse the trend of infection and drug design in combating SARS-CoV-2.

Acknowledgements

We would like to thank the Director General of Health, Ministry of Health, Malaysia, for his permission to publish this article. We also would like to thank the ASEAN Secretariat and GIZ-ASEAN COVID-19 Project Team for their valuable assistance during the execution of the project with the ASEAN Member States.

The study was approved by the National Medical Research Registration (NMRR) of Ministry of Health, Malaysia (Approval No. NMRR-20-904-54809 (IIR)).

Contributor Information

Noriah Binti Mohd Yusof, National Public Health Laboratory, Ministry of Health, Putrajaya, Malaysia.

Zhi Shan Khor, Faculty of Information Science and Technology, Multimedia University, Melaka, Malaysia.

Rehan Shuhada Binti Abu Bakar, National Public Health Laboratory, Ministry of Health, Putrajaya, Malaysia.

Kamal Hisham Bin Kamarul Zaman, National Public Health Laboratory, Ministry of Health, Putrajaya, Malaysia.

Yu Kie Chem, National Public Health Laboratory, Ministry of Health, Putrajaya, Malaysia.

Nur Aina Fatini, National Public Health Laboratory, Ministry of Health, Putrajaya, Malaysia.

Nur Hazliza Binti Salleh, National Public Health Laboratory, Ministry of Health, Putrajaya, Malaysia.

Selvanesan Sengol, National Public Health Laboratory, Ministry of Health, Putrajaya, Malaysia.

Savuth Chin, National Public Health Laboratory, National Institute of Public Health, Phnom Penh, Cambodia.

Sitha Prum, National Public Health Laboratory, National Institute of Public Health, Phnom Penh, Cambodia.

Visal Chhe, National Public Health Laboratory, National Institute of Public Health, Phnom Penh, Cambodia.

Phally Vy, National Public Health Laboratory, National Institute of Public Health, Phnom Penh, Cambodia.

Aizzuddin Mirasin, Department of Laboratory Services, Ministry of Health, Brunei.

Nur Amirah Ibarahim, Department of Laboratory Services, Ministry of Health, Brunei.

Izzati Azhar, Department of Laboratory Services, Ministry of Health, Brunei.

Muhd Haziq Fikry Abdul Momin, Department of Laboratory Services, Ministry of Health, Brunei.

Nor Azian Hafneh, Department of Laboratory Services, Ministry of Health, Brunei.

Hartanti Dian Ikawati, National Referral Laboratory Prof. Sri Oemijati, Center for Resilience and Human Resources, Health Policy Agency, Jakarta, Indonesia.

Hana Apsari Pawestri, National Referral Laboratory Prof. Sri Oemijati, Center for Resilience and Human Resources, Health Policy Agency, Jakarta, Indonesia.

Arie Ardiansyah Nugraha, National Referral Laboratory Prof. Sri Oemijati, Center for Resilience and Human Resources, Health Policy Agency, Jakarta, Indonesia.

Kartika Dewi Puspa, National Referral Laboratory Prof. Sri Oemijati, Center for Resilience and Human Resources, Health Policy Agency, Jakarta, Indonesia.

Archawin Rojanawiwat, Department of Medical Sciences, Ministry of Public Health, National Institute of Health, Yasothon, Thailand.

Pilailuk Akkapaiboon Okada, Department of Medical Sciences, Ministry of Public Health, National Institute of Health, Yasothon, Thailand.

Siripaporn Phuygun, Department of Medical Sciences, Ministry of Public Health, National Institute of Health, Yasothon, Thailand.

Thanutsapa Thanadachakul, Department of Medical Sciences, Ministry of Public Health, National Institute of Health, Yasothon, Thailand.

Pakorn Piromtong, Department of Medical Sciences, Ministry of Public Health, National Institute of Health, Yasothon, Thailand.

Hoang Vu Mai Phuong, National Institute of Hygiene and Epidemiology (NIHE), Ðà Nãng, Vietnam.

Ung Thi Hong Trang, National Institute of Hygiene and Epidemiology (NIHE), Ðà Nãng, Vietnam.

Nguyen Phuong Anh, National Institute of Hygiene and Epidemiology (NIHE), Ðà Nãng, Vietnam.

Nguyen Vu Son, National Institute of Hygiene and Epidemiology (NIHE), Ðà Nãng, Vietnam.

Le Thi Thanh, National Institute of Hygiene and Epidemiology (NIHE), Ðà Nãng, Vietnam.

Noorliza Mohamad Noordin, National Public Health Laboratory, Ministry of Health, Putrajaya, Malaysia; National Institute of Hygiene and Epidemiology (NIHE), Ðà Nãng, Vietnam.

Joon Liang Tan, Faculty of Information Science and Technology, Multimedia University, Melaka, Malaysia.

Funding

This study is a part of the support under the project ‘Strengthening Regional Initiatives in ASEAN on COVID-19 Response and other Public Health Emergencies’, an immediate COVID-19 support programme of the German Federal Ministry of Economic Cooperation and Development (BMZ), implemented by the Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ) GmbH.

Author Contributions

J.L.T. and N.M.N. conceived the project; J.L.T. and Z.S.K. performed the bioinformatics analyses; N.M.Y., R.S.A.B., K.H.K.Z., N.A.F., N.H.S., Y.K.C., S.S., A.M., N.A.I., I.A., M.H.F.A.M., N.A.H., S.C., S.P., V.C., H.D.I., H.A.P., A.A.N., A.R., P.A.O., S.P., H.V.M.P., U.T.H.T., P.V., K.D.P., T.T., P.P., N.V.S., L.T.T. and N.P.A. performed the experiments and assembly; all authors have read and approved the manuscript.

Conflicts of Interest statement. None declared.

References


Articles from Journal of Travel Medicine are provided here courtesy of Oxford University Press

RESOURCES